Analysis

Latest Analysis

The United States Cannot Afford Disarray as China Strengthens Its Biopharmaceutical Industry

The United States should remember that leadership in biopharmaceutical innovation is driven by its unparalleled R&D ecosystem. Arbitrary changes in funding and rules threaten U.S. bioinnovation leadership and the nation’s health, welfare, and national security.

Commentary by Sujai Shivakumar, Charles Wessner, and Julie Heng — March 18, 2025

Growing Challenges for the Semiconductor Design Industry: The United States Cannot Take Leadership for Granted

Report by Sujai Shivakumar, Charles Wessner, and Thomas Howell — February 25, 2025

Photo: wassana/Adobe Stock. Image was generated with AI.

Innovation Lightbulb: Innovation Competition in Chip Design Between the U.S. and China

Newsletter by Hideki Tomoshige — February 21, 2025

Albany NanoTech’s Potential to Support the National Semiconductor Technology Center

Report by Charles Wessner and Thomas Howell — February 14, 2025

Innovation Lightbulb: Basic Research for Breakthrough Innovations

Newsletter by Julie Heng — February 7, 2025

See all analysis by RAI

Subscribe to our bi-weekly program newsletter, The Innovation Hub

Recharged? The Future of Europe's Auto Sector and EU-China Relations

TotalEnergies’ Energy Outlook: Navigating the Future of Global Energy

Streamlining Government Coordination for a More Rights Based Approach to Supply Chain Transparency

Strategic Landpower Dialogue: The Army's Transformation Priorities

Departments

Programs